Clinical Trial Update: A Study of 2 Doses of a Hepatitis B Vaccine (V232 RECOMBIVAX HB) in Healthy Infants (V232-057) [Phase 3]

View source ↗

Summary

This is a Phase 3 trial evaluating two doses of the Hepatitis B vaccine (Recombivax HB) in healthy infants. The study has completed and posted results in 2009.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• Recombivax HB (Hepatitis B vaccine)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Hepatitis B | Phase 3 | Status: COMPLETED | Results posted: 2009-04-14